Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
47.87
+0.95 (2.02%)
Jun 3, 2026, 1:47 PM EDT - Market open

KNSA Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,6833,1471,4341,2361,044813
Market Cap Growth
92.27%119.41%16.06%18.37%28.45%-32.56%
Enterprise Value
3,2552,7401,1991,040856.08633.31
Last Close Price
47.8741.2519.7817.5414.9811.77
PE Ratio
52.5655.00-87.705.76-
Forward PE
37.6427.3242.93---
PS Ratio
4.934.643.394.574.7421.09
PB Ratio
5.715.543.272.822.644.39
P/TBV Ratio
6.365.743.222.882.664.36
P/FCF Ratio
22.6223.0756.4493.83183.11-
P/OCF Ratio
22.3922.8155.8492.92179.80-
EV/Sales Ratio
4.324.042.833.853.8916.43
EV/EBITDA Ratio
34.3034.78--70.31-
EV/EBIT Ratio
34.9235.48--87.60-
EV/FCF Ratio
19.8220.0847.1778.92150.14-
Debt / Equity Ratio
0.010.010.020.020.010.01
Debt / EBITDA Ratio
0.100.12--0.49-
Debt / FCF Ratio
0.060.070.390.931.04-
Net Debt / Equity Ratio
-0.76-0.71-0.53-0.44-0.47-0.95
Net Debt / EBITDA Ratio
-4.84-5.145.328.49-15.171.14
Net Debt / FCF Ratio
-2.79-2.97-9.20-14.74-32.391.39
Asset Turnover
0.951.010.760.550.640.13
Inventory Turnover
1.261.912.121.271.814.95
Quick Ratio
3.143.092.843.584.484.15
Current Ratio
3.793.793.304.345.164.38
Return on Equity (ROE)
12.45%11.73%-9.85%3.37%63.10%-63.55%
Return on Assets (ROA)
15.38%15.35%-6.64%-14.54%-41.30%-53.33%
Return on Invested Capital (ROIC)
47.30%39.05%-13.76%-28.79%-105.00%-520.64%
Return on Capital Employed (ROCE)
14.42%13.98%-9.68%-5.76%3.25%-61.96%
Earnings Yield
1.97%1.82%-1.14%17.36%-
FCF Yield
4.42%4.33%1.77%1.07%0.55%-
Buyback Yield / Dilution
-11.98%-10.58%0.69%-2.13%-2.69%-10.89%
Total Shareholder Return
-11.98%-10.58%0.69%-2.13%-2.69%-10.89%
SEC Filings: 10-K · 10-Q